MF59
MF59 has been studied in 3 papers since 2017: none in people yet, 1 in animals, 2 reviews; 1 in the past year. The research so far is in animals. The newest paper, Nov 14, 2026: “Immunosenescence and vaccine adjuvants in older adults: from immune decline to signal reconstitution strategies”.
3 papers study it1 findingUpdated
1 new paper in 30 daysSee all 3 papers on MF59
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: European Commission and 1 more
- Animals1
What did studies of MF59 find?
1Studies of MF59 measured one outcome, inflammation.
Inflammation
upin mice1
1 study
Inflammation
upin mice1
MF59 induces inflammation in mice.
“the addition of MF59 induced IL-5, granulocyte colony-stimulating factor (G-CSF), Keratinocyte Chemotractant (KC) and monocyte chemoattractant protein 1 (MCP1) in all ages of animals”
Animals
Inflammatory responses to influenza vaccination at the extremes of age
Immunology
Latest
1 paper in 12 monthsClinical Infectious Diseases
Precision Vaccine Adjuvants for Older Adults: A Scoping Review
Systematic reviewInterventions
Immunology
Inflammatory responses to influenza vaccination at the extremes of age
Experiments in miceImmune response